Skip to main content
logo
Orchid Pharma Limited (NSE:ORCHPHARMA)
India flag India · Delayed Price · Currency is INR
983.45
-13.55 (-1.36%)
Oct 1, 2026, 3:30 PM IST

Orchid Pharma Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
99.591,351921.67463.18-19.51
Depreciation & Amortization
429.7418.5321.07547.79869.93
Other Amortization
2.761.6911.310.080.31
Loss (Gain) From Sale of Assets
-79.283.331.88-399.85-0
Loss (Gain) From Sale of Investments
-26.33--0.15-5.12
Loss (Gain) on Equity Investments
6.61-38.9928.9821.5435.23
Provision & Write-off of Bad Debts
-210.5558.17-2.6511.8836.67
Other Operating Activities
298.74-352.6856.05329.54298.27
Change in Accounts Receivable
-396.05-188.83196.47-416.54-229.19
Change in Inventory
850.54-611.8-354.88-560.8225.37
Change in Accounts Payable
292.4-325.51548.51139.14473.63
Change in Other Net Operating Assets
-38.1172.79-468.4847.59325.86
Operating Cash Flow
1,256513.711,260183.38924.75
Operating Cash Flow Growth
144.57%-59.23%587.05%-80.17%292.07%

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-3,896-1,536-648.15-849.13-144.04
Sale of Property, Plant & Equipment
90.924.01-585.460.99
Divestitures
----1,594
Investment in Securities
814.65957.49-2,592-53.07-326.55
Other Investing Activities
121.83209.6120.024.614.88
Investing Cash Flow
-2,769-364.83-3,120-312.141,129

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Short-Term Debt Issued
1,701335.59---
Long-Term Debt Issued
---1,732199.99
Total Debt Issued
1,701335.59-1,732199.99
Long-Term Debt Repaid
-228.52-183.29-2,200-1,098-2,048
Total Debt Repaid
-228.52-183.29-2,200-1,098-2,048
Net Debt Issued (Repaid)
1,472152.3-2,200633.92-1,848
Issuance of Common Stock
--3,919--
Other Financing Activities
-100.95-127.73-48.96-322.26-320.12
Financing Cash Flow
1,37124.571,670311.66-2,168

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Cash Flow
-141.05173.45-189.96182.91-113.87

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
-2,640-1,022611.77-665.75780.71
Free Cash Flow Growth
----239.71%
Free Cash Flow Margin
-21.41%-7.31%7.47%-10.00%13.95%
Free Cash Flow Per Share
-44.08-17.0712.65-16.3119.13
Levered Free Cash Flow
-1,862-2,217-2,498-1,0482,206
Unlevered Free Cash Flow
-1,806-2,137-2,396-846.732,406

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
100.95127.7348.96322.26320.12
Cash Income Tax Paid
-23.53151.45-6.292.9919.06
Change in Working Capital
708.8-953.35-78.38-790.62595.66